Authors
Loading...
Randomized trial explores PCSK9 mutations impact on LDL receptor activity, suggesting potential for new treatments.
Benjannet et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: